ImmVira Presented Clinical Results of Oncolytic Product MVR-C5252 Targeting Malignant Glioma via Convection-Enhanced Delivery at 2025 AACR Annual Meeting
SUZHOU, China, April 28, 2025 /PRNewswire/ -- From April 25 to April 30, 2025, U.S. time, ImmVira presented the Phase I clinical results of its oncolytic Herpes Simplex Virus ("oHSV") product MVR-C5252 targeting malignant glioma through poster...
Patrick Tan appointed as Duke-NUS Dean to lead next era of medical innovation and education
SINGAPORE, April 11, 2025 /PRNewswire/ -- Duke-NUS Medical School has appointed Professor Patrick Tan as its next and fourth Dean, effective 1 January 2026, marking a new chapter for the School as it builds on its legacy of medical education,...
Duke and Duke-NUS forge new frontiers in climate health research with S$1million funding
The two institutions awarded more than S$1 million to accelerate five promising areas of research collaboration Dedicated Research Collaboration Pilot Project grant combines expertise from Singapore and the US for bigger impact First time in the...